We are live on
!
Find out more
AGN.PRA
Allergan plc
AGN.PRA
AGN.PRA
Delisted
AGN.PRA was delisted on the 28th of February, 2018.
116 hedge funds and large institutions have $3.14B invested in Allergan plc in 2016 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 39 increasing their positions, 31 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
120% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 10
26% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 31
7% more funds holding
Funds holding: 108 → 116 (+8)
5% less capital invested
Capital invested by funds: $3.3B → $3.14B (-$156M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
116
Holders Change
+8
Holders Change %
+7.41%
% of All Funds
3.1%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.13%
New
22
Increased
39
Reduced
31
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$76.2M |
| 2 |
HCM
Highbridge Capital Management
New York
|
+$38.9M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$34.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$34.6M |
| 5 |
SC
Sculptor Capital
New York
|
+$33.3M |
